Publications by authors named "Leah Teoh"

Claim this Profile
M
Missing radiographic data handling in randomized clinical trials in rheumatoid arthritis.
Xiaohong Huang, Lixia Jiao, Lynn Wei, Hui Quan, Leah Teoh

J Biopharm Stat· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels.
Edward A Panacek, John C Marshall, Timothy E Albertson, David H Johnson, Steven Johnson, Leah Teoh

Crit Care Med· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.
Edward C Keystone, Arthur F Kavanaugh, John T Sharp, Hyman Tannenbaum, Ye Hua, Leah S Teoh

Arthritis Rheum· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial.
Rodger D MacArthur, Mark Miller, Timothy Albertson, Edward Panacek, David Johnson, Leah Teoh

Clin Infect Dis· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.
Michael H Weisman, Larry W Moreland, Daniel E Furst, Michael E Weinblatt, Edward C Keystone, Leah S Teoh

Clin Ther· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.
Michael E Weinblatt, Edward C Keystone, Daniel E Furst, Larry W Moreland, Michael H Weisman, Leah A Teoh

Arthritis Rheum· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis